Peripheral Vascular Disease and Peripheral Neuropathy in Individuals With Cardiometabolic Clustering and Obesity
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Two lower-extremity diseases (LEDs), including peripheral neuropathy and peripheral vascular disease (PVD), are leading causes of disability in the U.S. Although LEDs can be complications of diabetes, their prevelances and risk factors apart from diabetes are poorly described. This study describes the prevalence of LEDs and examines the association of obesity and cardiometabolic clustering in a population-based sample. RESEARCH DESIGN AND METHODS: Adults aged ≥40 years (n = 2,514) were evaluated in the 2001–2004 National Health and Nutrition Examination Survey for clustering of two or more cardiometabolic characteristics, including elevated triglycerides or plasma glucose, low HDL cholesterol levels, increased waist circumference, or hypertension. Clustering was combined with BMI (dichotomized at ≥30 kg/m2) to generate three groups: obese (with or without clustering); nonobese with clustering; and nonobese without clustering. Multivariate logistic regression procedures incorporated the complex survey sampling design. RESULTS: Overall, 9.0% of individuals had peripheral neuropathy alone, 8.5% had PVD alone, and 2.4% had both LEDs. The obese group was more likely to have peripheral neuropathy (odds ratio 2.20 [95% CI 1.43–3.39]), PVD (3.10 [1.84–5.22]), and both LEDs (6.91 [2.64–18.06]) compared with nonobese subjects without clustering. Within the nonobese group, clustering increased the odds of peripheral neuropathy (1.50 [1.00–2.25]) and PVD (2.48 [1.38–4.44]) compared with no clustering. CONCLUSIONS: Obesity and clustering markedly increased the likelihood of LEDs in this sample and identified a group for whom preventive activities may reduce the risk of future disability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“Adipocytokines may act as inflammatory mediators in systemic inflammation and vascular resistance in diabetes and cardiovascular disease (21,22).”
BackgroundWildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618 · cited 3×
“These factors and their corresponding risk cut points have been used previously (15,19).”
BackgroundMethodSelf-citationNational Center for Health Statistics ( NCHS )
Feinleib, M. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a16042 · Cited by 1,574
Obesity, Metabolic Syndrome, and Cardiovascular Disease
Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0372 · Cited by 1,371
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Peripheral arterial disease in people with diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3333 · Cited by 953
Peripheral Arterial Disease in People With Diabetes
Hoyt, R. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2095 · Cited by 649
Lower Extremity Foot Ulcers and Amputations in Diabetes
Reiber, G. E., Boyko, E. J., & Smith, D. G. (1995) · Medical Entomology and Zoology · Cited by 604
Diehm, C., Allenberg, J. R., Pittrow, D., Mahn, M., Tepohl, G., Haberl, R. L., Darius, H., Burghaus, I., & Trampisch, H. J. (2009) · Circulation · doi:10.1161/circulationaha.109.865600 · Cited by 593
Gregg, E. W., Sorlie, P., Paulose-Ram, R., Gu, Q., Eberhardt, M. S., Wolz, M., Burt, V., Curtin, L., Engelgau, M., & Geiss, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1591 · Cited by 585
Ziegler, D., Rathmann, W., Dickhaus, T., Meisinger, C., Mielck, A., & for the KORA Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1796 · Cited by 397
Metabolic syndrome and cardiovascular disease
Qiao, Q., Gao, W., Zhang, L., Nyamdorj, R., & Tuomilehto, J. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307780480963 · Cited by 376
Microvascular complications of impaired glucose tolerance
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2867 · Cited by 372
The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy
Feng, Y., Schlösser, F. J., & Sumpio, B. E. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.05.017 · Cited by 369
Diabetic neuropathy and oxidative stress
Pop-Busui, R., Sima, A., & Stevens, M. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.625 · Cited by 286
Mechanisms of disease: The oxidative stress theory of diabetic neuropathy
Figueroa-Romero, C., Sadidi, M., & Feldman, E. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9104-2 · Cited by 284
Costa, L. A., Canani, L. H., Lisbôa, H. R. K., Tres, G. S., & Gross, J. L. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01124.x · Cited by 197
Resnick, H. E., Vinik, A. I., Schwartz, A. V., Leveille, S. G., Brancati, F. L., Balfour, J., & Guralnik, J. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1642 · Cited by 135
Gregg, E. W., Gu, Q., Williams, D. E., de Rekeneire, N., Cheng, Y. J., Geiss, L. S., & Engelgau, M. M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.005 · Cited by 134
Idiopathic neuropathy patients are at high risk for metabolic syndrome
Smith, A. G., Rose, K., & Singleton, J. R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.005 · Cited by 132
Neuropathy: mobility and quality of life
van Schie, C. H. M. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.856 · Cited by 130
Idiopathic neuropathy, prediabetes and the metabolic syndrome
Smith, A. G., & Singleton, J. R. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.11.020 · Cited by 129
Small fiber neuropathy is associated with the metabolic syndrome
Pittenger, G. L., Mehrabyan, A., Simmons, K., Amandarice, Dublin, C., Barlow, P., & Vinik, A. I. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.113 · Cited by 116
INSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE
Cleland, S. J., Petrie, J. R., Ueda, S., Elliott, H. L., & Connell, J. M. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.t01-15-.x · Cited by 102
New Insights into the Mechanisms of Diabetic Neuropathy
Vincent, A. M., & Feldman, E. L. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000032411.11422.e0 · Cited by 95
The Eurodiab study: What has this taught us about diabetic peripheral neuropathy?
Tesfaye, S. H., & Selvarajah, D. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0070-1 · Cited by 67
Cited by
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Selvarajah, D., Kar, D., Khunti, K., Davies, M. J., Scott, A. R., Walker, J., & Tesfaye, S. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30081-6 · Cited by 556
Diabetic Foot Complications and Their Risk Factors from a Large Retrospective Cohort Study
Al-Rubeaan, K., Al Derwish, M., Ouizi, S., Youssef, A. M., Subhani, S. N., Ibrahim, H. M., & Alamri, B. N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124446 · Cited by 451
The effects of obesity on skeletal muscle regeneration
Akhmedov, D., & Berdeaux, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00371 · Cited by 241
“In addition to abnormalities discussed here, obese and type 2 diabetic individuals suffer from complications, such as peripheral neuropathy, which we do not address directly in this review (reviewed in Vincent et al., 2011; Ylitalo et al., 2011).”
Background
Metadata
- Authors
- Ylitalo, K. R., Sowers, M., & Heeringa, S.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Sowers, MaryFran
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-06-17
- Volume
- 34
- Issue
- 7
- Pages
- 1642-1647
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3120210
- OpenAlex
- W2143354630
- Cited by
- 85
- References
- 27
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 5 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 9 · 2019: 10 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 7 · 2013: 6 · 2012: 3
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- peripheral vascular disease, peripheral neuropathy, obesity, prevalence, risk factors, disability, NHANES
- MeSH terms
- Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, Humans, Male, Middle Aged, Nutrition Surveys, Obesity, Peripheral Nervous System Diseases, Prediabetic State, United States, Prevalence, Peripheral Vascular Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.